Scienjoy Holding Corp

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $151k $27.0m $26.7m $28.0m ($4.3m) $5.4m ($84.0m)
Net Income (Loss) Available to Common Stockholders, Basic $28.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $151k $27.0m $26.7m $28.3m ($4.9m) $3.7m ($85.1m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $29.8m $26.0m $21.7m
Net Income (Loss) Attributable to Noncontrolling Interest $274k ($590k) ($1.8m) ($1.1m)
Amortization of Intangible Assets $24k $26k $268k $642k $1.0m $981k $955k $923k
Depreciation $85k $117k $167k $174k $154k $171k
Deferred Income Tax Expense (Benefit) $87k ($191k) $298k $50k ($203k) ($628k) ($211k) ($12.6m)
Share-based Payment Arrangement, Noncash Expense $5.0m ($1.7m) $1.9m $1.4m $1.1m
Goodwill, Impairment Loss $26.6m
Impairment of Intangible Assets (Excluding Goodwill) $57.0m
Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss ($4.2m)
Equity Method Investment, Realized Gain (Loss) on Disposal $3.0m $25.4m $739k
Gain (Loss) on Disposition of Property Plant Equipment $2k ($1k) ($2k)
Income (Loss) from Equity Method Investments ($787k) $1.2m
Income Tax Expense (Benefit) $1.1m $879k $2.6m $1.2m $1.7m ($11.5m)
Operating Lease, Expense $6.4m $7.5m $10.1m $7.2m
Other Nonoperating Income (Expense) $1.0m $220k $1.2m
Changes in operating assets and liabilities:
Noncash investing and financing activities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $10.8m ($3.7m) $16.2m ($7.6m) ($4.7m) ($7.9m)
Increase (Decrease) in Accounts Payable $4.4m $2.9m $3.7m ($6.1m) ($5.1m) ($2.8m)
Accounts Receivable, Credit Loss Expense (Reversal) ($1.3m) ($250k) $397k $2.5m $4.2m $18.2m
Purchases of property and equipment, accrued but unpaid $167k $218k $312k $69k $135k $120k
Foreign Currency Transaction Gain (Loss), before Tax ($216k) ($266k) $521k ($224k)
Gain (Loss) on Investments $3.7m ($4.4m) ($787k) $1.2m
General and Administrative Expense $5.2m $10.2m $8.8m $10.6m $10.5m $12.7m
Goodwill $14.1m $14.4m $25.1m $25.7m $25.0m
Investment Income, Interest $245k
Marketable Securities, Unrealized Gain (Loss) $3k
Operating Costs and Expenses $937k
Proceeds from Contributions from Affiliates $247k $34k
Revenue from Contract with Customer, Including Assessed Tax $186.8m $177.5m
Stock or Unit Option Plan Expense $1.3m $1.3m $1.3m $1.3b
Unrealized Gain (Loss) on Derivatives $2.6m $1.6m
Net Cash Provided by (Used in) Operating Activities $107.3m ($716k) $23.8m $18.2m $8.3m $14.5m $9.4m $10.1m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $553k $457k $167k $218k $312k $69k $135k $120k
Gain (Loss) on Sale of Investments $3.6m
Net Cash Provided by (Used in) Investing Activities ($553k) ($57.5m) ($6.3m) ($18.1m) ($16.4m) ($9.5m) ($2.7m) ($868k)
Cash flows from financing activities:
Payments for Repurchase of Common Stock $385k $101k
Net Cash Provided by (Used in) Financing Activities ($170.9m) $58.2m ($3.6m) $2.4m ($1.7m) ($735k) ($18k) ($14k)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($3.8m) ($43k) $221k ($17k) ($202k) ($1.3m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13.4m $2.5m ($9.5m) $4.2m $6.4m $7.9m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $34.6m $44.0m
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net ($3.5m) ($7.0m) ($6.9m) ($9.5m) $9.1m $13.4m ($2.2m) ($1.2m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.